Agoracom Blog Home

Archive for the ‘Medical Marijuana Stocks’ Category

« Older Entries
Newer Entries »

Creator of Charlotte’s Web marijuana strain says Canada legislation is archaic

Posted by AGORACOM-JC at 2:18 PM on Tuesday, April 29th, 2014
CTVNews.ca Staff
Published Tuesday, April 29, 2014 11:14AM EDT

The developer of a special strain of marijuana marketed to children hopes to convince Health Canadato allow the product in the country, as some Canadian families head south of the border to receive the drug that’s been shown to significantly reduce seizures.

Colorado cannabis producer Josh Stanley and his brothers developed Charlotte’s Web — a special strain of marijuana oil with very little THC and very high cannabidiol (CBD), the component believed to reduce seizures.

The marijuana extract is designed not to produce a high, but instead fight seizures through its high level of anti-inflammatory properties.

Josh Stanley, the developer of a special strain of marijuana marketed to children, hopes to convince Health Canada to allow the product in the country.

The strain is named in honour of Charlotte Figi, a U.S. girl who was losing a lifelong battle to epilepsy until she began using the marijuana oil.

“When we had met Charlotte, unfortunately, her family had signed a do-not-resuscitate order,” Stanley told CTV’s Canada AM on Tuesday.

Charlotte was diagnosed with Dravet Syndrome, a rare and catastrophic form epilepsy that begins in infancy. Prior to testing the oil she was suffering from about 350 seizures a week.

Doctors had told the Figi family there were few options left for the youngster after the majority of anti-epileptic drugs had failed to work. Neurologists removed Charlotte from the drugs she had been prescribed. She began using the cannabis oil as an end of life comfort measure.

“Immediately after starting this all-natural, organic treatment, she went from 350 seizures to zero,” Stanley said. “And two-and-a-half years later she remains 97- per cent seizure-free.”

The marijuana extract is produced in Colorado, but state law does not allow the shipment or sale of marijuana products out-of-state.

Stanley said this has led to the creation of “medical refugees.” He said a number of families have moved to Colorado from throughout the U.S., and some from Canada, to receive the treatment.

“Kids come there and get the treatment, but then they become prisoners in Colorado,” he said. “They’re not able to leave the state.”

Since that winter of 2012 more than 180 pediatric epilepsy patients have started treatment. Stanley said “thousands” of others are on the waiting list, including some children from Canada.

Health Canada does not permit the sale of cannabis resins, oils, extractions and edible marijuana products. Only dry medical marijuana can be sold to clients.

Stanley described the medical marijuana legislation in Canada as “archaic.”

“Heath Canada seems to want to push kids to smoking, or people to smoking, because extracts are not allowed,” he said.

Stanley said the best way to change health officials’ minds about the marijuana oil is to “show them they have a problem.”

“What we’re talking about here is life or death for many of these children,” he said.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , ,
Posted in All Recent Posts, Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Creator of Charlotte’s Web marijuana strain says Canada legislation is archaic

Medical marijuana gives epileptic child new lease on life

Posted by AGORACOM-JC at 4:26 PM on Monday, April 28th, 2014

AIRDRIE, Alta. ─ Potato chip producers and Grateful Dead fans have always believed, but a desperate mother in Airdrie, Alta., never thought she’d be calling marijuana a miracle.

The cries of “mama, mama” from Sarah Wilkinson’s living room just north of Calgary are all she needs to believe ─ that, and seeing her disabled eight-year-old daughter Mia going from 100 seizures a day to seven in the past eight months.

“Her first seizure was 29 minutes after birth ─ it was absolutely terrifying,” said Wilkinson.

“From there I was thrust into the world of seizure disorders. At first I thought it would resolve itself, and then the doctor sat us down and told us it was terminal.”

Mia was born with Ohtahara syndrome, an extremely rare epilepsy syndrome usually caused by a brain abnormality, and typically fatal within the first two years of life.

Children who survive longer, like Mia, are severely disabled.

Their parents can spend years in a desperate search, for something, anything, to reduce the number and severity of seizures, with the worst ─ called status seizures ─ lasting as long as 22 hours.

Last July, Wilkinson and her husband James had run out of options, and after seeing Mia in hospital ICU, fighting back from yet another brutal seizure and a medically-induced coma, they were ready to give up.

“Her neurologist had looked at me and said there’s nothing else we can do,” said Wilkinson.

“She’d had another status seizure and was in a medically-induced coma and my husband and I said this is it — I looked at him and said ‘I’m not doing this to her anymore, it’s not fair to her.'”

Having gone through dozens of drugs and procedures, Wilkinson said there was nowhere else to go, and to keep bringing Mia back from the brink seemed cruel, even if her life between the awful seizures often seemed happy.

“She laughs and plays with toys and she absolutely adores Lady Gaga,” said Wilkinson.

But worsening seizures and no further pharmaceutical options made the situation hopeless ─ all that was left was marijuana, an herb that has shown promise for other epileptic patients, but none so young.

Wilkinson didn’t really believe in marijuana as medicine ─ “I assumed people who wanted it just wanted to get high” ─ and before Mia’s breakthrough she only counted herself as an advocate for hockey and her two older sons: “I was a militant hockey mom, maybe.”

But with nothing to lose, she asked anyway.

“There was no way a doctor will prescribe medical marijuana for a pediatric patient, but we were ready to sign a ‘no resuscitation’ order and speak with a palliative team,” said Wilkinson.

“So I asked, because it was all that was left. The doctor said, ‘We are at the end of our pharmaceutical rope. Let’s do it.'”

Images of a child smoking bud are far from the truth: the pot is cooked to extract the medicinal agents, then mixed with coconut oil.

Just one day after Mia tasted her first marijuana, there were drastic changes.

“Within 24 hours her seizures stopped,” said Wilkinson. An electroencephalography test showed the herb had somehow calmed her raging brain.

“They said her EEG was comparable to someone with a benign form of epilepsy ─ that’s never happened before.”

The marijuana miracle is still a mystery.

Mia’s doctors want to know which of the roughly 500 compounds in cannabis is working, and why, but that would require an expensive DNA test to even get started — and because she was deemed terminal shortly after birth, public funding for a genetic breakdown has not been available.

“We need to find out why. It won’t change the course of treatment for Mia, but it can for hundreds of other children suffering from intractable seizure disorders,” wrote Wilkinson on a GoFundMe page dedicated to raising cash for that DNA test.

Meanwhile, Mia is happy at home ─ driving her mom nuts.

Unable to speak at all prior to the prescription for pot, Mia now has three words in her vocabulary, including “yes,” “no” and “mama,” plus she’s finally learning to walk.

“She started talking ─ I’m not really liking the ‘no,'” laughs Wilkinson.

“And ‘mama’ is all I hear anymore. I bawled when I first heard it.”

[email protected]

Source: http://www.torontosun.com/2014/04/26/medical-marijuana-gives-epileptic-child-new-lease-on-life

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in All Recent Posts, Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Medical marijuana gives epileptic child new lease on life

AGORACOM Now Dominates Searches For Small Cap Medical Marijuana Stocks

Posted by AGORACOM at 9:47 AM on Friday, April 25th, 2014

Good morning to you all.  We’re very proud to announce that just a couple of months into our small cap medical marijuana stocks initiative, which includes branding and marketing on behalf of 3 of the best such companies (see here), AGORACOM is dominating search engines queries for small cap medical marijuana stocks.  In the image below, you can see the results of a generic Google search for the term “small cap medical marijuana stocks”.

We are very proud of this achievement because search engines like Google reward content that is fresh (constantly updated) and diverse (mixture of videos, blogs, social media, etc.) which ultimately provides users with the most relevant content possible.

Thanks to our awesome small cap medical marijuana clients and our massive small cap audience of AGORACOM members and visitors.  We promise to continue being worthy of the privilege.

A PICTURE IS WORTH 1,000 WORDS

AGORACOM Dominates Search Engines Small Cap Medical Marijuana Stocks

Posted in AGORACOM Traffic, Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on AGORACOM Now Dominates Searches For Small Cap Medical Marijuana Stocks

GreenRush Financial Conferences Inc. Announces Speaker and Exhibitor Lineup May 7th Vancouver Conference

Posted by AGORACOM-JC at 8:38 AM on Friday, April 25th, 2014

–GreenRush Financial Conferences’ (a wholly owned subsidiary of Next Gen) Vision: To be the Premier Purveyor of Investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries

-The first two Conferences are to be held in Vancouver and Toronto

-Vancouver, British Columbia – Wednesday May 7, 2014 at the Vancouver Convention and Exhibition Centre East, Ballrooms A/B/C in the Pan Pacific Hotel

-Toronto, Ontario – June 2014, Date TBA

-Further conferences are also slated for Canada, the United States and Europe

-The conference will highlight investments in health, agri-business, food, legal grow-ops, technology, client generation, education, public awareness, specialty clinics and auxiliary business opportunities throughout the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

-The Conference will feature “Industry Experts”, “Investment Experts”, “Corporate Presentations”, “Media Power Hour”, and “The Great Debate Q & A Session”, followed by “A Party with a Purpose!!!”

-For further information and to register as an attendee please visit our website at www.greenrushfinancialconferences.com.

Vancouver, British Columbia, Canada / April 25, 2014 / Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce the initial list of speakers and exhibitors at its inaugural GreenRush Financial Conference to be held in Vancouver, British Columbia on May 7th 2014. GreenRush Financial Conferences objective is to provide a platform/hub to facilitate investment, education and business to business opportunities across the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

Harry Barr, President and CEO stated, “The Medical Marijuana, Industrial Hemp and Alternative Medicine industries all have the potential for exponential growth. Recent North American legislation has dramatically changed our industry’s ability to finance existing and new projects. With that in mind GreenRush Financial Conferences will act as a financial hub for these three emerging industries and will facilitate both education and investment across the industries. We look forward to hosting Canada’s first Medical Marijuana, Industrial Hemp and Alternative Medicine Investment conference in Vancouver, BC on May 7th, 2014.”

Please visit www.greenrushfinancialconferences.com
for more information on our speakers and exhibitors.

About GreenRush Financial Conferences

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

The first conference will held in Vancouver, British Columbia on Wednesday May 7th, 2014 at the Vancouver Convention and Exhibition Centre East, Ballrooms A/B/C in the Pan Pacific Hotel. The second conference will be held in Toronto, Ontario in June 2014 – TBD. Further conferences are also slated for Canada, the United States and Europe.

For more information on GreenRush Conferences please visit our website at

www.greenrushfinancialconferences.com, email us at [email protected] or contact us by phone at (604) 685-1870.

About Next Gen

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)

Next Gen is a diversified Canadian public company which focusses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry. Next Gen’s Vision is to be the Leading Provider of Venture Capital for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.

Next Gen’s business model generates new business plans and industry related proposals on an ongoing basis. Management continues to receive and review the proposals from various segments of the industry including: alternative medicine, health, food, agri-business, legal grow-ops, technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. For further information, visit our website at www.nextgenmetalsinc.com.

In light of Next Gen’s vision, Management’s objective is to invest in a basket of companies within this growing industry. The company’s business model continues to generate new business plans and project submittals 24/7.

For further information on GreenRush Financial Conferences please contact us by phone or at [email protected] or [email protected].

For further information and general Investor Relations Inquiries please contact us by phone or email at [email protected].

Tel: +1 604 685 1870 Fax: +1 604 685 8045 Website: http://www.nextgenmetalsinc.com
650-555 West 12th Avenue, City Square, West Tower, Vancouver, B.C., Canada, V5Z 3X7
On behalf of the Board of Directors

“Harry Barr”

Harry Barr

President & CEO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

The CSE has neither reviewed nor approved the contents of this News Release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Medical Marijuana Stocks, Next Gen | Comments Off on GreenRush Financial Conferences Inc. Announces Speaker and Exhibitor Lineup May 7th Vancouver Conference

Lexaria Announces Managers of Ontario Facility and First Phase Production Plans

Posted by AGORACOM-JC at 8:20 AM on Friday, April 25th, 2014

Kelowna, British Columbia–(April 25, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria“) is pleased to announce the appointment of its management team for its new Ontario marijuana production facility.

Mr. Don Shaxon has been named Lexaria’s Ontario Operations Manager, having responsibility for Lexaria’s current facility as well as potential future production locations. Don has nearly 20 years experience in the public markets, and has worked in the cannabis industry in the USA for both Cannabis Science Inc and for Endocan Corp; and more recently has joined Enertopia Corp. Don held a Canadian medical marijuana production licence under the recent MMAR program. Don will be intimately involved in production design, layout, and ongoing operations.

“Words cannot describe how truly excited I am to be running the Ontario operations for Enertopia and Lexaria. The healing properties of cannabis are undeniable and it’s a great feeling for me, knowing we’ll be supplying Canadian patients with the quality medicine they rightfully deserve. I’m very much looking forward to solidifying our position as a leader in the emerging medical marijuana industry in Canada.” said Don Shaxon. Mr. Shaxon has been instrumental in assembling the new Ontario team for the Lexaria/Enertopia joint venture project and Lexaria extends its thanks for his important contributions.

Lexaria is also announcing Mr. Jason Springett as Master Grower for the new facility. Jason is currently serving on the Lexaria Advisory Board where he will remain, and he will now add all the responsibilities of Master Grower. Jason has extensive knowledge and experience in the medical marijuana sector having been a licensed grower under existing Health Canada regulations for many years. He has experience with multi-strain growing including THC-free CBD strains; with both organic growing and non-toxic pest control and non organic growing techniques; with yield optimizations strategies such as highly monitored and controlled light, heat, CO2; remote monitoring and controls, and much more.

“Our operations team have the expertise and ambition to build this Ontario marijuana production facility into one of the world’s best, and we will settle for nothing less.” said Chris Bunka, CEO of Lexaria “The Lexaria/Enertopia joint venture is gaining traction and we continue to add talented world-class individuals to our growing team.”

Lexaria also reports that, following a site visit last week, design and engineering of the facility is underway. HVAC, electrical, structural, production optimization and floor design, and plant and process security are just some of the aspects of the project that are now being planned.

The project is being designed as one of Canada’s largest and most advanced marijuana production facilities. Production areas are expected to be completed in either two or three stages, with an initial production area of 20,000 – 25,000 square feet being contemplated at this time. Ultimate production capacity at this location is up to 65,000 square feet on a single floor, or more if a second floor design is utilized in whole or in part.

Each of the managers are eligible to receive up to 577,500 restricted common shares of stock over time in their respective roles as an Advisory Board members, depending on certain specified performance thresholds being reached.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Manager: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business or any member of the operations team will provide any benefit to Lexaria, nor that a first phase of construction will involve 25,000 square feet or will be completed, or that the Company will be successful in obtaining a Health Canada license under the MMPR program.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , ,
Posted in All Recent Posts, Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Announces Managers of Ontario Facility and First Phase Production Plans

Lexaria Adds to Management Team

Posted by AGORACOM-JC at 8:08 AM on Thursday, April 24th, 2014

 

Kelowna, BC / April 24, 2014 / Lexaria Corp. (LXRP-OTCQB) (LXX-CSE) (the “Company” or “Lexaria”) is pleased to announce new Managers joining the Company and assisting in the development and growth of the Ontario marijuana production facility.

Mr. Greg Boone has been named Lexaria’s Human Resource Manager, with the responsibility of placing key managers and executives not just in the new Ontario production facility, but also Company-wide as necessary. Greg is the President of HEC Group, an executive search and management consulting company that specializes in building high performance teams to build and grow emerging companies. For more than 15 years Greg has built relationships with a significant network of professionals in many industrial sectors, including food, pharmaceutical, regulatory/quality assurance, logistics/supply chain, and more. Greg will also assist in establishing key human resource policies at the new facility.

“I am excited and truly pleased to be joining the Lexaria organization. I look forward to spearheading the recruitment efforts to attract expertise in various disciplines to solidify our position as a leader in the emerging medical marijuana industry in Canada,” said Greg Boone.

Lexaria is also pleased to welcome Mr. Clark Kent as Media Manager to implement media needs for the new Ontario production facility as well as broader Company media strategies. Clark has over 8 years experience in media management, communications and marketing and will be a single point of contact for media and communications enquiries within Canada. He has previous experience in fields such as resources and also in medical diagnostics. Clark will produce corporate marketing materials and work with the media to ensure consistent and concise messaging.

“I welcome both Greg and Clark and I know their contributions will help position Lexaria for the success we are striving towards.” said Chris Bunka, CEO of Lexaria “Key appointments such as these, and the knowledge and experience represented by these latest members of our team, will continue to enable Lexaria to distinguish itself in this rapidly emerging industry through the quality and dedication of its people.”

The consultants are each eligible to receive up to 577,500 restricted common shares of stock over time in their respective roles as an Advisory Board members, depending on certain specified performance thresholds being reached.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.

Chris Bunka, Chairman & CEO: (250) 765-6424

Clark Kent, Media Manager: (647) 519-2646

 

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business or any member of the Advisory Board or Management team will provide any benefit to Lexaria.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Adds to Management Team

Enertopia Announces Greg Boone Human Resources Manager

Posted by AGORACOM-JC at 8:00 AM on Thursday, April 24th, 2014

Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce additional Consultants to the Company and for the new Ontario marijuana production facility.

Mr. Greg Boone has been named Enertopia’s Human Resource Manager, with the responsibility of placing key managers and executives not just in the new Ontario production facility, but also Company-wide as necessary. Greg is the President of HEC Group, an executive search and management consulting company that specializes in building high performance teams to build and grow emerging companies. For more than 15 years Greg has built relationships with a significant network of professionals in many industrial sectors, including food, pharmaceutical, regulatory/quality assurance, logistics/supply chain, and more. Greg will also assist in establishing key human resource policies at the new facility.

“I am excited and truly pleased to be joining the Enertopia organization. I look forward to spearheading the recruitment efforts to attract expertise in various disciplines to solidify our position as a leader in the emerging medical marijuana industry in Canada,” said Greg Boone.

Enertopia is also pleased to welcome Mr. Clark Kent as Media Manager to implement media needs for the new Ontario production facility as well as broader Company media strategies. Clark has over 8 years experience in media management, communications and marketing and will be a single point of contact for media and communications enquiries within Eastern Canada. He has previous experience in fields such as resources and also in medical diagnostics. Clark will produce corporate marketing materials and work with the media to ensure consistent and concise messaging.

“I welcome both Greg and Clark and I know their contributions will help position and help move Enertopia for the success we are striving towards.” said Robert McAllister, President / CEO of Enertopia “Key appointments such as these, and the knowledge and experience represented by these latest members of our team, will continue to enable Enertopia to distinguish itself through the quality and dedication of its people.”

Enertopia continues to focus on accretive facility acquisitions that reduce project risk but at the same time increase significantly the potential production space and the long term viability of the Company.

The consultants are each eligible to receive up to 472,500 restricted common shares of stock over time in their respective roles as an Advisory Board members, depending on certain specified performance thresholds being reached. Enertopia continues to build its team of experts and consultants in all aspects of its business and expects to continue this growth in the near future.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Clark Kent at 1.647.519.2646 or Dale Paruk, President, Coal Harbor Communications Ltd. at 1.604.662.4505

 

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, evaluation of clean energy projects, Oil & Gas Projects, Medical Marihuana Projects  for participation and/or financing, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements.  Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates.  The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.  There is no assurance that the Company will be successful in completing any anticipated financing and or its joint Venture partners will receive their Health Canada license under the new regulations or any will future sales will result or any consultant will have a material impact on the Company.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , ,
Posted in All Recent Posts, Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Announces Greg Boone Human Resources Manager

Enertopia Provides Corporate Update

Posted by AGORACOM-JC at 8:00 AM on Thursday, April 17th, 2014

Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia“) is pleased to announce it continues to get strong option and warrant conversion interest.

Enertopia is also pleased to announce that 651,045 warrants have been exercised raising $110,209 and a further 50,000 options have been exercised for $7,500 for total consideration of $117,709 in net proceeds.

MMJ Projects update, World of Marihuana is awaiting the Health Canada site visit, as soon as the exact date is known, Enertopia will provide this information to the market place. The Green Canvas Ltd. is rapidly moving forward with their site renovations and the phase one build out for production space has been increased from 6,400 square feet to 14,000 square feet. The total phase one build out for the production, vegging, safe, lab, and shipping rooms will be 29,000 square feet.

“These are exciting times for Enertopia and we look forward to further updates shortly with exceptional opportunities for our company in the Medical Marihuana Business sector. Stated President / CEO Robert McAllister

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Dale Paruk, President, Coal Harbor Communications Ltd. at 1.604.662.4505

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, evaluation of clean energy projects, Oil & Gas Projects, Medical Marihuana Projects  for participation and/or financing, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements.  Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates.  The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.  There is no assurance that the Company will be successful in completing any anticipated financing and or its joint Venture partners will receive their Health Canada license under the new regulations.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in All Recent Posts, Enertopia, Medical Marijuana Stocks | Comments Off on Enertopia Provides Corporate Update

Lexaria Welcomes Jeff Paikin to Advisory Board

Posted by AGORACOM-JC at 8:35 AM on Monday, April 14th, 2014

Kelowna, British Columbia–(April 14, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce the appointment of a new expert to its Advisory Board, specializing in facility construction and management.

Mr. Jeff Paikin has joined Lexaria’s Advisory Board. Mr. Paikin is well known throughout the Greater Toronto area as President of the New Horizon Development Group and for his extensive community involvement. Mr. Paikin is the past Chair and a current Board Member of the Canadian Accredited Independent Schools (CAIS); a member of the Hamilton Tiger-Cats Advisory Board, and for 29 years has been on the Committee of B’Nai Brith Sports Celebrity Dinner in Hamilton, ON.

Mr. Paikin was named Hamilton’s Royal Bank of Canada Distinguished Citizen of the Year for 2013. He is a past Member of the Campaign Cabinet for The Children’s Aid Society and of the Hamilton Health Sciences Foundation, among many others.

“Lexaria is taking a professional and appropriate step-by-step methodical approach to building its medical marijuana business,” said Mr. Paikin. “I’m excited to be part of this new industry at its formative stage.”

Mr. Paikin is eligible to receive up to 525,000 restricted common shares of stock over time in his role as an Advisory Board member, depending on certain specified performance thresholds being reached. Lexaria continues to build its team of experts and consultants in all aspects of its business and expects to continue this growth in the near future.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business or any member of the Advisory Board will provide any benefit to Lexaria.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Welcomes Jeff Paikin to Advisory Board

Lexaria Intends to Complete a $1,960,000 Financing

Posted by AGORACOM-JC at 8:10 AM on Monday, April 14th, 2014

Kelowna, British Columbia–(April 14, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered private placement financing, consisting of 7,000,000 Equity Units at US $0.28 per unit, to raise gross proceeds of up to US $1,960,000 (the “Private Placement”).

Each equity unit will consist of one common share of the Company and one non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of eighteen months from the date of issuance, at a purchase price of US$0.50. The Company may accelerate the expiry date of the warrants if the stock price trades above CAD$0.60 for 20 consecutive days at any time after 6 months and one day has elapsed.

Lexaria may pay broker commissions of up to 6.0% in cash and 6% in broker warrants in connection with the Private Placement. Each broker’s warrant will be exercisable into one single common share (a “Warrant Share”) at a price of US$0.50 per Warrant Share for a period of eighteen (18) months following closing of the Offering. Certain directors, officers and insiders of the Company may participate in the Private Placement.

The Company is canceling its earlier announced intention to complete a non-brokered private placement financing, consisting of 5,000,000 Equity Units at US $0.45 per unit, to raise gross proceeds of up to US $2,250,000 (the “Private Placement”). Market conditions have made that proposed financing redundant.

The securities issued will be subject to a hold period in Canada of four months and one day, or for any resales possible into the USA under Rule 144, six months and one day. Proceeds from the equity units will be used for corporate development in the Medical Marijuana business, G&A and general working capital. The Private Placement will be subject to normal regulatory approvals.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria and no assurance that the proposed financing of up to $1,960,000 will be successful.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Intends to Complete a $1,960,000 Financing

« Older Entries
Newer Entries »